Key Stats for Monster Beverage Stock
- Past-Week Performance: 3%
- 52-Week Range: $51 to $84
- Current Price: $84
What Happened to Monster Beverage Stock?
Monster Beverage (MNST) surged to $83.76, just $0.22 below its 52-week high of $83.98 and up 64.5% from its 52-week low of $50.93, as HSBC raised its price target to $98 from $82 on February 3 and JP Morgan lifted its target to $79 from $75 on February 10, both ahead of the company’s Q4 2025 earnings call scheduled for February 26.
HSBC’s target raise to $98 represented the more significant vote of confidence, implying roughly 17% upside from current levels, while JP Morgan’s concurrent lift to $79 added institutional weight to a stock that has nearly doubled off its lows in under a year.
Both upgrades reflect growing conviction that Monster occupies the highest-growth lane in the beverage sector, with energy drinks commanding premium multiples relative to traditional soda staples precisely because the category sits outside the GLP-1 dietary disruption and FDA scrutiny of processed refined carbohydrates hitting legacy food and beverage brands.
The market is rapidly repricing Monster less as a Coca-Cola distribution asset and more as an independent growth compounder, as Reuters Breakingviews explicitly identified the stock as Coca-Cola’s primary growth hedge in January while simultaneously flagging that Celsius represents a fast-growing competitive threat requiring Monster to defend its category leadership.
Adding near-term urgency, Monster announced on February 19 that CEO Hilton Schlosberg will host the Q4 2025 earnings webcast on February 26 after market close, making the current price action a pre-earnings momentum setup with investors positioning ahead of results that will either confirm or challenge the stock’s proximity to 52-week highs.
The bigger picture here is that Monster is trading like a category winner at a moment when traditional beverage incumbents including Coca-Cola, whose incoming CEO called for faster innovation on February 10, and PepsiCo, which is scrambling to reformulate its entire snack portfolio, are visibly struggling to adapt, leaving the energy drink segment as one of the clearest structural growth stories in consumer staples.
Wall Street’s Take on MNST Stock
With MNST trading at $83.76 and within $0.22 of its 52-week high, the February 26 Q4 2025 earnings call hosted by CEO Hilton Schlosberg now becomes the single most important near-term catalyst to determine whether the stock breaks out to new highs or consolidates after a 64.5% recovery from its lows.
The fundamental case supporting a breakout is compelling, with Street estimates projecting 2025 revenue of $8.2 billion, up 9.5% year-over-year, normalized EPS of $2.00, up 23.2%, and EBITDA margins expanding to 31.9% from 26.8% in 2024, marking a decisive margin recovery that justifies the stock’s rapid re-rating.
Wall Street currently prices 23 analyst targets at a mean of $80.94, with 11 buys and 3 outperforms against 11 holds and 1 sell, meaning the stock has already surpassed the consensus mean target of $80.94 and now trades above what the average analyst expected, a dynamic that typically forces upward target revisions after a strong earnings print.
The target range for MNST stock runs from a low of $60 to a high of $98, a spread that reflects genuine uncertainty over whether Monster can defend category leadership against Celsius and other fast-growing rivals while simultaneously expanding internationally as Coca-Cola leans on the partnership to offset its own stagnating legacy soda volumes.
What Does the Valuation Model Say?
Even accounting for the stock’s run to near 52-week highs, a mid-case valuation model built on Monster beverage stock’s margin recovery and 8.6% revenue CAGR through 2030 prices MNST at $102.77, projecting a 22.7% total return and a 5.4% annualized IRR, a modest but positive return profile that depends heavily on the February 26 earnings confirming the 2025 margin expansion story.
In summary. the primary risk is competitive pressure from Celsius and other energy drink challengers compressing Monster’s category share precisely as the stock trades at peak valuation, with any sign of volume deceleration or gross margin miss on February 26 likely triggering a sharp pullback from levels that have already outrun the analyst consensus mean.
Therefore, at $83.76, MNST stock looks fairly valued to slightly ahead of itself relative to the $80.94 consensus mean, making it a wait-and-see ahead of February 26 earnings, where a strong Q4 print would justify the premium and potentially push the stock toward HSBC’s $98 target.
Value Any Stock in Under 60 Seconds (It’s Free)
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
